<DOC>
	<DOCNO>NCT02250989</DOCNO>
	<brief_summary>The objective study investigative influence different level glycaemia insulinemia vascular endothelium ischemia/reperfusion lesion myocardial infarction</brief_summary>
	<brief_title>The Influence Glycaemia Insulinemia Vasomotor Endothelial Function After Myocardial Infarction</brief_title>
	<detailed_description>The study include patient consecutively admit acute myocardial infarction State University Campinas Hospital . Participants evaluated hospitalization , fulfill inclusion criterion sign inform consent , collect brief medical history record result glycated hemoglobin ( HbA1c ) , glycaemia , total cholesterol ( TC ) , triglyceride ( TG ) , HDL cholesterol ( HDL-C ) , C-reactive protein ( CRP ) , urea ( U ) , creatinine ( Cr ) , marker myocardial necrosis ( troponin T CK-MB ) , Hemoglobin , Red blood cell , Leucocytes , Na , K , Ca Mg . In first week infarction , admission realization clamp experiment ( medical procedure blood glucose insulin level control ) , medication prescribe , medical history examination record , well follow-up hospitalization . At day clamp , 144 168 hour infarction , volunteer randomize one three situation different glycemic insulinemic condition , i.e. , ) high insulinemia low glycaemia , b ) high insulinemia high glycaemia c ) low insulinemia high glycaemia . During experiment , endothelial vasomotor function record four period : ) initiation procedure , ii ) 1h beginning , iii ) 30 minute second procedure iv ) 15 minute simulation ischemia/reperfusion lesion . In time point , investigator collect plasma dose inflammatory , oxidative stress vascular activation marker . Hospital care subject The patient include survey treat accord actual guideline . Briefly , enrol patient underwent primary angioplasty within 6 hour symptoms onset , introduce antiplatelet anticoagulation therapy correct dose , respectively Acetylsalicylic Acid ( ASA ) 200 mg Clopidogrel 300 mg , enoxaparin 30 mg . In patient without contraindication , administer first 24 hour beta-blockers ACEi ejection fraction ( EF ) &lt; 0.4 , previous MI prior heart failure . Upon admission , contraindication , simvastatin 40 mg/day administer . As maintenance dose , investigator administer ASA 100 mg , clopidogrel 75 mg , enoxaparin 1 mg/kg twice daily , simvastatin 40 mg , propranolol 40 mg metoprolol 50 mg ( beta-blockers available hospital ) captopril 25 mg ( use ACEi ) . Patients treat preferably Coronary Unit ( CU ) . Researchers may suggest physician responsible patient care prescribe medication , well question drug list guideline use . The reason specific contraindication record . The researcher directly responsible treatment individual , absolve responsibility adverse effect related experiment . Also , investigator emphasize study interfere flow patient hospitalization , i.e. , influence discharge patient . Randomization one three clamp As observed , investigator evaluate endothelial reactivity FMD . On day clamp , fasting , expose one three situation : ( ) hyperglycemia / hypoinsulinemia , ( ii ) euglycaemia / hyperinsulinemia ( iii ) hyperglycemia / hyperinsulinemia . The clamps simulate possible attenuation increase endothelial reactivity promote independent variable ischemia/reperfusion ( I/R ) injury . In total , test consist realization basal FMD-1 ( 15 minute ) , clamp ( variable length , usually 60 minute ) , FMD-2 ( 15 min ) clamp , rest time ( 30 min ) , ischemia/reperfusion ( 20 min ) injury , rest time ( 15 min ) FMD-3 ( 15 min ) . Throughout experiment , blood glucose insulin control maintained level design previously clamp situation . In subject , plasma sample collect start clamp ( FMD-1 ) , end measurement second FMD clamp , prior I/R injury 15 minute end test ( FMD-3 ) . In sample dose insulin , glucose , C-peptide , C-reactive protein , tumor necrosis factor-α ( TNF-α ) , nitric oxide , intercellular adhesion molecule-1 ( ICAM-1 ) , plasminogen activator inhibition-1 ( PAI-1 ) , isoprostane interleucin-1 ( IL-1 ) . In one group , euglycemic/hyperinsulinemic consist situation insulin level physiological level blood glucose level maintain approximately 100 mg/dL . Euglycemic/hyperinsulinemic clamp similar way hyperinsulinemic/hyperglycemic clamp perform , although reach glucose level approximately 150 mg/dL . During clamp hypoinsulinemia/hyperglycemia , infuse somatostatin analogue ( octreotide ) 30 minute ( = 0 min ) subsequently infusion 20 % glucose achieve glycaemia approximately 150 mg/dL ( = 30 min ) . Ischemia/Reperfusion Injury The I/R injury intend simulate brachial artery condition similar coronary lesion result infarction reperfusion . This experiment perform 30 min measurement FMD-2 , position pneumatic cuff level brachial artery , inflate 200 mmHg 15 minute . After period ischemia , cuff deflate subsequently perform brachial reactivity test . This ischemia period safe , show study . Statistical analysis Data present mean ± standard deviation ( SD ) normally distribute median interquartile range ( IQR ) non-normal data . Categorical variable compare chi-square . Continuous variable normal distribution compare use analysis covariance ( ANCOVA ) adjust age , gender , size MI estimate peak CK-MB estimate heart rate variability sympathetic activity . Prerequisites ANCOVA model ( linearity , normality equal variance ) check use histogram , normal probability plot residual dispersion . Non-normal continuous variable may transform logarithmically . If , transformation , persist normal , analyzed Kruskal-Wallis test . Analysis perform use SPSS 22 application , Mac version .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Plasminogen Activator Inhibitor 1</mesh_term>
	<criteria>less 12 hour onset symptom STEMI , reperfusion therapy perform less 6 hour symptom onset . patient 24 hour show marker myocardial necrosis diabetes use oral antidiabetic admission glycosylated hemoglobin ≥ 6.5 % patient creatinine clearance &lt; 50 ml / min , patient BMI ≥ 40 kg / m2 , premenopausal woman , patient use nitrate vasoactive drug ( norepinephrine , dobutamine , nitroglycerin nitroprussiate 48h prior examination endothelial function cardiac dysfunction acute MI without repercussion clinic , diagnose ejection fraction le 50 % leave ventricle . FMD value 2 standard deviation average test</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Endothelial disfunction</keyword>
	<keyword>Intercellular Adhesion Molecule-1</keyword>
	<keyword>Vascular Cell Adhesion Molecule-1</keyword>
	<keyword>8-epi-prostaglandin F2alpha</keyword>
	<keyword>Nitric Oxide</keyword>
	<keyword>Plasminogen Activator Inhibitor 1</keyword>
	<keyword>Endothelin-1</keyword>
	<keyword>Tumor Necrosis Factor-alpha</keyword>
	<keyword>Glucose</keyword>
	<keyword>Insulin</keyword>
	<keyword>C-peptide</keyword>
	<keyword>C-reactive protein</keyword>
	<keyword>3-nitrotyrosine</keyword>
</DOC>